Maze Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Maze Therapeutics, Inc. has announced its 2026 Annual Meeting of Stockholders will be held virtually on June 8, 2026, to elect directors and ratify auditor appointment.